Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation Page 4 • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth • 17 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Steve Newlin Appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2013 2014 and beyond -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $38.38 March 7th, 2014 • 17 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 5 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% United States 66% Europe 14% Canada 7% Asia 6% Latin America 7% PP&S 20% Specialty 53% Distribution 27% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target Ad ju st ed E ar ni ng s P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 6 PolyOne At A Glance Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty Specialty OI $5M $46M $87M $195M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 7 2006 2013 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.2% 12 – 16% Global Specialty Engineered Materials 1.1% 9.3% 12 – 16% Designed Structures & Solutions -- 5.6% 8 – 10% Performance Products & Solutions 5.4% 7.2% 9 – 12% Distribution 2.6% 5.9% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 62% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.1% 15% 4) Adjusted EPS Growth N/A 31% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 8 Bridge To $2.50 Adjusted EPS By 2015 2015 EPS: $2.50 2013 EPS: $1.31 Mid single digit revenue CAGR Page 9 Mergers & Acquisitions Spartech accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 10 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Healthcare Consumer Packaging and Additive Technology Transportation Page 11 Unique and Innovative Solutions that Help Customers Win https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG Net Debt / EBITDA* = 1.8x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of December 31, 2013 ($ millions) Page 12 Coupon Rates: 7.500% 7.375% 5.250% Debt Maturities & Pension Funding – 12/31/13 *TTM 12/31/2013 ** includes US-qualified plans only 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2013 Pension Funding** As of December 31, 2013 Free Cash Flow and Strong Balance Sheet Fund Investment •Targets that expand our: • Specialty offerings •End market presence •Geographic footprint •Operating Margin • Synergy opportunities •Adjacent material solutions •Expanding our sales, marketing, and technical capabilities • Investing in operational and LSS initiatives (including synergy capture) •Manufacturing alignment Organic Growth Share Repurchases Dividends Acquisitions Page 13 $0.16 $0.20 $0.24 $0.32 $0.00 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend • Repurchased ~5 million shares in 2013 • 15 million shares are available for repurchase under the current authorization The New PolyOne: A Specialty Growth Company 2015 Target: $2.50 Adjusted EPS Why Invest In PolyOne? Strong past performance demonstrates that our strategy and execution are working • Megatrends align with our strengths • Innovation and services provide differentiation, incremental pricing power, and competitive advantage • Strong and proven management team driving growth and performance • Addressable market exceeds $40 billion Page 14 1 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S. Appendix At a Glance�Global Specialty Engineered Materials At a Glance�Global Color, Additives, and Inks At a Glance�Designed Structures and Solutions At a Glance�Performance Products and Solutions At a Glance�Distribution Plastics: Key to Future Sustainable Development Establish Lean Six Sigma As Way of Life Application Examples Slide Number 24 2012 Range Rover Evoque Interior Slide Number 26 Slide Number 27 Metal Replacement Solutions High-Barrier Packaging Containers Aerospace Applications Sidoti Reconciliation of Non-GAAP.pdf Section 1

Bir pozisyon için başvurduğunuz yerel Avient kuruluşunun yasal mercisi kişisel bilgileriniz konusunda veri denetleyicisi olarak hareket edecektir. 1. Bize Ulaşın Herhangi bir sorunuz varsa veya haklarınızı kullanmak isterseniz bize aşağıdaki adresten ulaşabilirsiniz: Kurumsal Gizlilik Yetkilisi Avient Corporation 33587 Walker Road Avon Lake, Ohio 44012 E-posta: PRIVACY.OFFICER@AVIENT.COM Telefon: 1-800-901-2078 mailto:PRIVACY.OFFICER@AVIENT.COM Gizlilik sorularınız veya taleplerinizi bize çevrimiçi formumuzu doldurarak da gönderebilirsiniz. Geçerlilik Tarihi: 1 Ağustos 2020 https://privacyportal.onetrust.com/webform/b25cf7b1-a93a-4d26-8c84-ceda4d0ae91b/e180cbe4-d1b9-49bd-b621-cb5f6a0f42cb mailto:PRIVACY.OFFICER@AVIENT.COM

主要特性 在三个通过ISO 13485认证的医疗生产线生 产全球统一的配方，提供全球一致性和供应 链保障 变更控制记录不限于CAS编号级别，降低变 更风险 • • 不含动物源性物质和邻苯二甲酸盐 可用作各种聚合物的母粒或即用型配方 为方便起见，可在一个产品中实现功能性和颜 色的组合 • • • 法规支持 经过预测试的原材料： - ISO 10993-1 - USP 第、章（VI类） - USP （指南），6.2.3 可萃取元素； USP - ICHQ3D/USP 2 可萃取金属 - 欧洲药典 3.1 聚烯烃（如适用） FDA发布的注册药品主文件（III类）和/或医疗 器械主文件 为符合（新）法规（如IVDR）的批准或过渡提 供文档支持 • • • 适用医疗保健使用限制—见下文。 在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。

وتابعیھا ("البائع") تسري ھذه الشروط والأحكام على بیع آفینت كوربوریشن للمنتجات إلى ("مشتري") آخر 1. القبول. 1 ("الشروط") على جمیع مبیعات لبائع وھذه الشروط والأحكامالخاص باطلب ال الشروط والأحكام الحصریة للبیع، باستثناء ما یعُدل بموجب اتفاق وھيالبائع، خطي یوقعھ الأطراف. Terms and Conditions (1 April 2024) 2024أبریل 1(الشروط والأحكام(

In order for ghosting to occur, these 5 factors must co-exist. 1.

Di el ec tr ic co ns ta nt Lo ss ta ng en t Di el ec tr ic co ns ta nt Frequency [GHz] Frequency [GHz] Pallet number (1250 kg/pallet) PREPERM™ PPE950 PREPERM™ PPE800 PREPERM™ PPE440 PREPERM™ PPE320 PREPERM™ PPE260 -- Dielectric constant target -- +/- 2% 3,76 3,78 3,80 3,82 3,84 3,86 3,88 3,90 3,92 3,94 0 1 2 3 4 5 6 7 8 D ie le ct ri c co ns ta nt P a llet number (1250 k g/pa llet ) Die le ctric cons ta nt ta rge t +/- 2 % 0,000 0,002 0,004 0,006 0,008 0,010 0 10 20 30 40 50 60 Lo ss t a ng en t F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 0,000 0,002 0,004 0,006 0,008 0,010 0 10 20 30 40 50 60 Lo ss t a ng en t F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 0,000 0,002 0,004 0,006 0,008 0,010 0 10 20 30 40 50 60 Lo ss t a ng en t F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 Copyright © 2022, Avient Corporation.

APPLICATION BULLETIN 1 Typical properties: these are not to be construed as specifications HOW TRILLIANT™ HC FORMULATIONS HELP TO SOLVE THE MOST DIFFICULT PERFORMANCE AND PROCESS CHALLENGES Trilliant HC conductive thermoplastics can be customized to meet your unique challenges.

PRODUCT BULLETIN PROPERTY TEST METHOD TYPICAL VALUE (ENGLISH) TYPICAL VALUE (SI) Specific Gravity ASTM D-792 11.0 11.0 Tensile Modulus1 ASTM D-638 1.20E+6 psi 8270 MPa Tensile Strength1 (Yield) ASTM D-638 3,950 psi 27.2 MPa Flexural Modulus ASTM D-790 800,000 psi 5520 MPa Flexural Strength ASTM D-790 7,000 psi 48.3 MPa Notched Izod Impact2 ASTM D-256A 2.1 ft•lb/in 110 J/m Deflection Temperature Under Load 66 psi (0.45 MPa), Unannealed, 0.250 in (6.35mm) ASTM D-648 280°F 138°C Deflection Temperature Under Load 264 psi (1.8 MPa), Unannealed, 0.250 in (6.35mm) ASTM D-648 190°F 87.8°C TECHNICAL PROPERTIES 1 Type I, 0.20 in/min (5.1 mm/min) 2 73°F (23°C), 0.125 in (3.18 mm), Injection molded www.avient.com Copyright © 2020, Avient Corporation.

This additive technology can be implemented during PET processing without impact on production efficiency. 0 10 20 30 40 50 60 70 80 0.050 0.1 0.15 0.2 % A A Re du ct io n % Use Rate Anthranilamide 0 10 20 30 40 50 60 70 80 90 .04 .06 .08.020 0.1 0.16 0.180.140.12 0.2 % A A Re du ct io n % Triple A-1+ 1.844.4AVIENT www.avient.com Copyright © 2022, Avient Corporation.

PRODUCT RANGE HIGHLIGHTS Amosorb™ 4020E • Non-nylon based oxygen scavenging technology for PET • Helps to prolong the shelf life of many products in major markets Amosorb™ 100 • Non-nylon based oxygen scavenging technology for PET • Developed to meet the needs of the North American market • Featuring a special additivation package to allow for pre-consumer regrind Amosorb™ 4020G • Lower haze levels and lower impact on PET recycle stream • Non-nylon based active oxygen scavenger • PET and rPET compatible • Can be used with mono-layer and multi-layer applications Amosorb™ 4020R • Consistent performance with all levels of rPET (25%, 50% and 100%) • Improved haze and color when in combination with rPET • Flexibility on choice of rPET grade • Non-nylon based product Amosorb™ SolO2 -1 (non-carbonated/ carbonated) and SolO2 -2 (carbonated) • Nylon based oxygen scavenging technologies for PET • Active barrier effect to prevent O2 ingress • Passive barrier effect to prevent gas ingress and digress from the packaging (i.e.